Veradermics Raises $75 Million in Series B Financing and Initiates Phase 2/3 Trial for Hair Loss by Seini Moimoi | Dec 11, 2024 | Portfolio News
Opna Bio Announces Interim Data from Phase 1 Combination Study of OPN-2853 with Ruxolitinib in Patients with Advanced Myelofibrosis by Seini Moimoi | Dec 9, 2024 | Portfolio News
WelbeHealth Expands PACE Access to Vulnerable Seniors with Opening of Carson Center by Seini Moimoi | Dec 3, 2024 | Portfolio News
Eflornithine and Lomustine Combination Shows Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma IDH Mutant Grade 3 by Seini Moimoi | Nov 22, 2024 | Portfolio News
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024 by Seini Moimoi | Nov 22, 2024 | Portfolio News
